ConvaTec Group PLC (CNVVY)
OTCMKTS · Delayed Price · Currency is USD
12.89
-0.25 (-1.90%)
Sep 10, 2025, 3:30 PM EDT
ConvaTec Group Market Cap
ConvaTec Group has a market cap or net worth of $6.49 billion as of September 10, 2025. Its market cap has increased by 1.13% in one year.
Market Cap
6.49B
Enterprise Value
7.72B
Revenue
2.36B
Ranking
n/a
PE Ratio
29.96
Stock Price
$12.89
Market Cap Chart
Since October 26, 2016, ConvaTec Group's market cap has increased from 5.37B to 6.49B, an increase of 20.83%. That is a compound annual growth rate of 2.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2025 | 6.49B | 14.58% |
| Dec 31, 2024 | 5.67B | -10.67% |
| Dec 29, 2023 | 6.34B | 10.75% |
| Dec 30, 2022 | 5.73B | 8.81% |
| Dec 31, 2021 | 5.26B | -3.23% |
| Dec 31, 2020 | 5.44B | 4.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 780.18M |
| Elite Pharmaceuticals | 742.62M |
| Glass House Brands | 596.87M |
| CytoDyn | 466.16M |
| Northwest Biotherapeutics | 375.53M |
| American Oncology Network | 345.48M |